Latest Strategic Reset News

Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.

Nufarm’s FY25 results reveal robust growth in crop protection and a strategic reset in seed technologies, with a significant reduction in net debt setting the stage for a stronger FY26.

Nufarm reported a mixed FY25 with strong crop protection profits offset by a statutory loss from seed restructuring, while targeting earnings growth and debt reduction in FY26.

KMD Brands reported a challenging FY25 with a net loss but has launched a transformative ‘Next Level’ strategy focused on cost reset, product innovation, and digital growth. Early FY26 trading shows promising sales momentum, signaling potential turnaround.

Energy World Corporation Ltd has outlined a strategic reset including a $442 million debt-to-equity conversion and is progressing towards commissioning its flagship Pagbilao LNG and power project in the Philippines, alongside advancing its Sengkang LNG facility in Indonesia.

Genetic Signatures Limited unveiled a year of strategic transformation and robust financial growth at its 2025 AGM, highlighting leadership renewal and a sharpened commercial focus. The company’s FY25 revenue jumped 66%, driven by strong product demand and expanded market presence.

Camplify Holdings reported a $15.8 million net loss for FY25 amid strategic consolidation and tech integration, while launching its MyWay membership model to drive future profitability.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

ANZ reported a 10% decline in statutory profit for FY2025, impacted by significant regulatory and restructuring charges, while reaffirming its ANZ 2030 strategy and maintaining a strong capital position.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its Milklab plant-based milk brand, while preparing for a significant convertible note maturity in 2027.

OzAurum Resources reports strong drilling results at its Mulgabbie North Gold Project and regains full control of its Feasibility Study, positioning the company for accelerated development amid record gold prices.